RESM holdings
Columbia Research Enhanced Small Cap ETF
Positions
1,040 stored of 1,040 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1001 | Ring Energy Inc | US76680V1089 | 76680V108 | 0.010% | $360 | Equity (common) | Corporate | United States | USD |
| 1002 | Perspective Therapeutics Inc | US46489V3024 | 46489V302 | 0.010% | $358 | Equity (common) | Corporate | United States | USD |
| 1003 | Verastem Inc | US92337C2035 | 92337C203 | 0.010% | $355 | Equity (common) | Corporate | United States | USD |
| 1004 | Fulcrum Therapeutics Inc | US3596161097 | 359616109 | 0.010% | $355 | Equity (common) | Corporate | United States | USD |
| 1005 | RE/MAX Holdings Inc | US75524W1080 | 75524W108 | 0.010% | $355 | Equity (common) | Corporate | United States | USD |
| 1006 | McGraw Hill Inc | US5809071039 | 580907103 | 0.010% | $350 | Equity (common) | Corporate | United States | USD |
| 1007 | Akebia Therapeutics Inc | US00972D1054 | 00972D105 | 0.009% | $347 | Equity (common) | Corporate | United States | USD |
| 1008 | Eledon Pharmaceuticals Inc | US28617K1016 | 28617K101 | 0.009% | $339 | Equity (common) | Corporate | United States | USD |
| 1009 | Pangaea Logistics Solutions Ltd | BMG6891L1054 | Not reported | 0.009% | $338 | Equity (common) | Corporate | Bermuda | USD |
| 1010 | Lexeo Therapeutics Inc | US52886X1072 | 52886X107 | 0.009% | $335 | Equity (common) | Corporate | United States | USD |
| 1011 | Compass Therapeutics Inc | US20454B1044 | 20454B104 | 0.009% | $326 | Equity (common) | Corporate | United States | USD |
| 1012 | Codexis Inc | US1920051067 | 192005106 | 0.009% | $325 | Equity (common) | Corporate | United States | USD |
| 1013 | Immuneering Corp | US45254E1073 | 45254E107 | 0.009% | $324 | Equity (common) | Corporate | United States | USD |
| 1014 | RxSight Inc | US78349D1072 | 78349D107 | 0.009% | $323 | Equity (common) | Corporate | United States | USD |
| 1015 | MapLight Therapeutics Inc | US56565P1030 | 56565P103 | 0.009% | $323 | Equity (common) | Corporate | United States | USD |
| 1016 | Microvast Holdings Inc | US59516C1062 | 59516C106 | 0.008% | $310 | Equity (common) | Corporate | United States | USD |
| 1017 | Embecta Corp | US29082K1051 | 29082K105 | 0.008% | $306 | Equity (common) | Corporate | United States | USD |
| 1018 | Designer Brands Inc | US2505651081 | 250565108 | 0.008% | $303 | Equity (common) | Corporate | United States | USD |
| 1019 | HMH Holding Inc | US40445M1009 | 40445M100 | 0.008% | $300 | Equity (common) | Corporate | United States | USD |
| 1020 | Evommune Inc | US30054Y1073 | 30054Y107 | 0.008% | $292 | Equity (common) | Corporate | United States | USD |
| 1021 | Upstream Bio Inc | US91678A1079 | 91678A107 | 0.008% | $291 | Equity (common) | Corporate | United States | USD |
| 1022 | LifeMD Inc | US53216B1044 | 53216B104 | 0.008% | $281 | Equity (common) | Corporate | United States | USD |
| 1023 | Anavex Life Sciences Corp | US0327973006 | 032797300 | 0.007% | $272 | Equity (common) | Corporate | United States | USD |
| 1024 | Atrium Therapeutics Inc | US04965N1046 | 04965N104 | 0.007% | $269 | Equity (common) | Corporate | United States | USD |
| 1025 | Zentalis Pharmaceuticals Inc | US98943L1070 | 98943L107 | 0.007% | $262 | Equity (common) | Corporate | United States | USD |
| 1026 | Angi Inc | US00183L2016 | 00183L201 | 0.007% | $256 | Equity (common) | Corporate | United States | USD |
| 1027 | Invivyd Inc | US00534A1025 | 00534A102 | 0.007% | $255 | Equity (common) | Corporate | United States | USD |
| 1028 | Tonix Pharmaceuticals Holding Corp | US8902608392 | 890260839 | 0.007% | $242 | Equity (common) | Corporate | United States | USD |
| 1029 | HighPeak Energy Inc | US43114Q1058 | 43114Q105 | 0.006% | $231 | Equity (common) | Corporate | United States | USD |
| 1030 | MNTN Inc | US55318A1088 | 55318A108 | 0.006% | $230 | Equity (common) | Corporate | United States | USD |
| 1031 | Karyopharm Therapeutics Inc | US48576U2050 | 48576U205 | 0.006% | $225 | Equity (common) | Corporate | United States | USD |
| 1032 | Keros Therapeutics Inc | US4923271013 | 492327101 | 0.006% | $225 | Equity (common) | Corporate | United States | USD |
| 1033 | CONTRA TREEHOUSE FOODS | Not reported | 894CVR018 | 0.005% | $184 | Equity derivatives | Other | United States | USD |
| 1034 | Amplify Energy Corp | US03212B1035 | 03212B103 | 0.005% | $183 | Equity (common) | Corporate | United States | USD |
| 1035 | Larimar Therapeutics Inc | US5171251003 | 517125100 | 0.005% | $180 | Equity (common) | Corporate | United States | USD |
| 1036 | PrimeEnergy Resources Corp | US74158E1047 | 74158E104 | 0.005% | $167 | Equity (common) | Corporate | United States | USD |
| 1037 | Lands' End Inc | US51509F1057 | 51509F105 | 0.004% | $147 | Equity (common) | Corporate | United States | USD |
| 1038 | Unicycive Therapeutics Inc | US90466Y2028 | 90466Y202 | 0.004% | $131 | Equity (common) | Corporate | United States | USD |
| 1039 | CONTRA AVADEL PHARMACE | USG29CVR0199 | Not reported | 0.004% | $131 | Equity derivatives | Other | Ireland | USD |
| 1040 | Infinity Natural Resources Inc | US4569411030 | 456941103 | 0.001% | $51 | Equity (common) | Corporate | United States | USD |